Linked infacebooktwitteryoutube
Novartis

Novartis and PTC Therapeutics Forge $2.9 Billion Partnership for Huntington’s Drug PTC518

HealthCare Global Enterprises

HCG and Accenture Partner to Transform Cancer Care with Advanced AI

GE HealthCare

GE HealthCare to Acquire Full Ownership of Nihon Medi-Physics, Expanding Molecular Imaging Leadership in Asia

Strand Life Sciences

Strand Life Sciences Unveils CancerSpot for Early Cancer Detection

Allink Biotherapeutics

Allink Biotherapeutics Secures $42 Million in Series A Financing to Accelerate Development of Next-Generation Oncology and Immunology Therapies

Apollo Cancer Centres

Apollo Cancer Centres Launch India’s First Lunglife Screening Programme for Early Detection of Lung Cancer

Agilus Diagnostics

Agilus Diagnostics Unveils Claudin 18.2 Test: A Breakthrough in Cancer Care

BioArctic

Leqembi® Launched in South Korea for Early Alzheimer’s Disease Treatment

QIAGEN

QIAGEN Expands QIAstat-Dx Operations with New Facility in Barcelona

SunAct Cancer Institute

SunAct Cancer Institute Partners with Abgentil Biomedical to Revolutionize Cancer Treatment in India

Dr. Reddy’s

Dr. Reddy’s Launches Toripalimab in India for Advanced Nasopharyngeal Carcinoma

Novartis

European Commission Approves Kisqali® for HR+/HER2- Early Breast Cancer at High Risk of Recurrence

BeiGene

European Commission Approves TEVIMBRA® for First-Line Treatment of ESCC and G/GEJ Adenocarcinoma

Theranostics

ICPO Theranostics Virtual Summit 2024: Advancing a New Era in Precision Oncology

Eisai Co., Ltd.

Eisai and Biogen Japan Collaborate with NCNP for APOE Genetic Testing in Alzheimer’s Research